Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 175 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/11/10
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 10/05/04
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 03/29/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/16/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/09/12
End: 09/30/31
Due: 09/30/32
Phase: N/A
Priority: Normal
Start: 01/29/02
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 12/31/97
End: 09/30/04
Due: 09/30/05
Phase: N/A
Priority: Normal
Start: 11/13/97
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/09/03
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 01/06/12
End: 02/06/12
Due: 02/06/13
Phase: N/A
Priority: Normal
Start: 01/22/04
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 12/07/90
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/15/97
End: 03/31/04
Due: 03/31/05
Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Phase: N/A
Priority: Normal
Start: 07/31/03
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 12/03/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/05/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/28/04
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 08/06/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/22/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 06/30/04
Due: 06/30/05
Phase: N/A
Priority: Normal
Start: 11/19/01
End: 05/27/11
Due: 05/27/12
Phase: N/A
Priority: Normal
Start: 09/01/98
End: 05/01/09
Due: 05/01/10
Phase: N/A
Priority: Normal
Start: 11/20/97
End: -
Due: -